Voluntary Exercise by Animals Prevents Weight Gain, Despite High-Fat Diet
CINCINNATIUniversity of Cincinnati (UC) researchers have found that animals on a high-fat diet can avoid weight gain if they exercise.
The study, led by Silvana Obici, MD, appears as a rapid electronic publication May 17, 2011, in the journal Endocrinology.
Obici and her team found that voluntary exercise activates leptin-receptor-positive neurons in the brains hypothalamus. Leptin is a hormone produced and released by fat and interacts with receptors in the hypothalamus known to inhibit appetite. High-fat diet-induced obesity results in the inability of leptin to suppress appetite, which is also known as leptin resistance.
The team tested whether preventing diet-induced weight gain by either exercise or calorie restriction would improve leptin resistance in mice. They found that leptin was ineffective at reducing body weight in sedentary mice on a restricted diet. However, they found that leptin significantly lowered body weight in active mice on a high-fat diet.
"What weve learned is that exercise helps to maintain a lower body weightdespite a high-fat dietperhaps through improved leptin action, says Obici, an associate professor in the division of endocrinology, diabetes and metabolism and researcher with UCs Metabolic Diseases Institute.
The results, Obici says, support the idea that exercise helps to keep weight off not only by burning calories through muscle activity, but also by influencing the brains response to the neural circuitry involved in energy balance.
The study was funded by grants from the American Diabetes Association and the National Institutes of Health. In addition, Kimberly Krawczewski Carhuatanta, first author and senior neuroscience graduate student at UC, was awarded a pre-doctoral fellowship from the American Heart Association to conduct this work.
Co-authors, all from the University of Cincinnati are Stephen Benoit, PhD, Giovanna Demuro, MD, Paul Pfluger, PhD, and Matthias Tschöp, MD.
Silvana Obici, MD
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.